Globus Medical (GMED) Shareholder's Equity Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.20% |
| Dec 31, 2025 | 35.30% |
| Sep 30, 2025 | 35.60% |
| Jun 30, 2025 | 36.23% |
| Mar 31, 2025 | 31.80% |
| Dec 31, 2024 | 33.87% |
| Sep 30, 2024 | 33.29% |
| Jun 30, 2024 | 34.36% |
| Mar 31, 2024 | 35.89% |
| Dec 31, 2023 | 38.46% |
| Sep 30, 2023 | 43.49% |
| Jun 30, 2023 | 14.08% |
| Mar 31, 2023 | 11.99% |
| Dec 31, 2022 | 9.60% |
| Sep 30, 2022 | 9.63% |
| Jun 30, 2022 | 9.69% |
| Mar 31, 2022 | 13.00% |
| Dec 31, 2021 | 13.67% |
| Sep 30, 2021 | 14.62% |
| Jun 30, 2021 | 14.32% |
| Mar 31, 2021 | 15.03% |
| Dec 31, 2020 | 15.89% |
| Sep 30, 2020 | 14.86% |
| Jun 30, 2020 | 13.88% |
| Mar 31, 2020 | 16.20% |
| Dec 31, 2019 | 19.01% |
| Sep 30, 2019 | 18.23% |
| Jun 30, 2019 | 18.21% |
| Mar 31, 2019 | 18.22% |
| Dec 31, 2018 | 18.34% |
| Sep 30, 2018 | 19.19% |
| Jun 30, 2018 | 19.49% |
| Mar 31, 2018 | 18.69% |
| Dec 31, 2017 | 18.24% |
| Sep 30, 2017 | 19.09% |
| Jun 30, 2017 | 19.67% |
| Mar 31, 2017 | 20.06% |
| Dec 31, 2016 | 20.77% |
| Sep 30, 2016 | 21.80% |
| Jun 30, 2016 | 22.69% |
| Mar 31, 2016 | 22.41% |
| Dec 31, 2015 | 22.78% |
| Sep 30, 2015 | 22.76% |
| Jun 30, 2015 | 25.98% |
| Dec 31, 2014 | 27.50% |